South Wales, July 31 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "Scira" on July 14. The details about the trademark application no. UK00004415980 published in the journal no. 2026/031 (July 31).
Scira Diagnostics Ltd filed the trademark application for the below mentioned good(s)/service(s).
Class 1 : Reagents for scientific and laboratory research; diagnostic reagents and preparations for scientific
and research use, other than for medical or veterinary purposes; biological and chemical preparations
for use in laboratories and in scientific research; nucleic acids, oligonucleotide primers, molecular
barcodes and enzymes for scientific and laboratory research use; assay kits comprising reagents for
scientific and laboratory research; reagents and preparations for detecting and analysing cell-free
DNA, chimerism, human leukocyte antigens, antibodies and genetic markers for scientific and research
purposes.
Class 5 : Diagnostic reagents and preparations for medical use; in vitro diagnostic reagents for medical
purposes; diagnostic test kits consisting primarily of reagents and assay preparations for medical
use; reagents and preparations for detecting and analysing donor-derived cell-free DNA, chimerism,
human leukocyte antigens, antibodies and genetic markers for medical diagnostic purposes; reagents
for medical genetic testing; reagents and preparations for detecting and monitoring transplant
rejection for medical purposes.
Class 10 : Medical and diagnostic apparatus and instruments; in vitro diagnostic apparatus and instruments for
medical use; point-of-care diagnostic testing apparatus and devices for medical use; lateral flow
test devices for medical diagnostic purposes; apparatus and devices for the collection, handling and
analysis of blood, plasma and urine samples for medical diagnostic purposes; diagnostic test kits
comprising medical apparatus and instruments.
Class 42 : Medical laboratory services.
Class 44 : Medical diagnostic testing services; medical analysis services for the diagnosis and monitoring of patients, including transplant recipients; genetic testing services for medical diagnostic purposes; medical testing services for the detection and monitoring of transplant rejection; health screening and medical monitoring services; provision of medical information relating to diagnostic testing and transplant monitoring.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004415980
Disclaimer: Curated by HT Syndication.
